Le Lézard
Classified in: Health
Subjects: MAV, CHI, TRI, DEI

MEDIA ADVISORY - Over 400 representatives of Montreal's business community join forces at the Sainte-Justine Winter Triathlon to raise $600,000 for children's charities


MONTREAL, Feb. 14, 2024 /CNW/ - The CHU Sainte-Justine Foundation invites media representatives to attend the Sainte-Justine Winter Triathlon, a Nordic challenge that each year brings together the business community around a single goal: to actively support CHU Sainte-Justine's mission.

This year's ambassador is Raphaël, a 10-year-old boy suffering from spondyloepiphyseal dysplasia, a genetic disease affecting the growth of the extremities of his bones. Raphaël and his parents will be available for interviews, as will Dr. Philippe Campeau, a genetic physician at CHU Sainte-Justine who has been trying for years to find the cause of the boy's disease.

DATE:

Friday, February 16, 2024

WHERE:

Maisonneuve Park Chalet - 4601 Sherbrooke St. E, Montreal

TIME:

1 p.m.

AVAILABLE FOR INTERVIEWS

SOURCE Winter Triathlon in support of the Sainte-Justine UHC Foundation


These press releases may also interest you

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced that it is scheduled to participate in the following upcoming events: 2024 RBC Capital Markets Global Healthcare Conference ? May 14-15, 2024 Type: Fireside Chat Presentation Date/Time: May 14,...

at 07:25
Prota Therapeutics' CEO Professor Mimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards. Professor Tang's exceptional work as a lead researcher for the Murdoch Children's Research Institute (MCRI) and her...

at 07:15
International medical imaging IT and Cybersecurity company Sectra's (STO: SECT B) digital pathology solution together with Leica Biosystems, Imaging, Inc.'s Aperio GT 450 DX have received a 510(k) clearance by the US Food & Drug Administration (FDA)....

at 07:11
Author C.A. Blake was 24 years old when her brother, Steve, committed suicide. She struggled with the feeling she wouldn't survive the pain of it. Growing up in a time where little to no coping skills were taught or offered, she traveled the path of...

at 07:05
Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that members of its executive team will participate at the following investor...

at 07:05
Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective...



News published on and distributed by: